|
|
||||||||
This article has been cited by other articles:
![]() |
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, H. Olsson, H. Adlercreutz, G. Landberg, and E. Wirfalt Enterolactone Is Differently Associated with Estrogen Receptor {beta}-Negative and -Positive Breast Cancer in a Swedish Nested Case-Control Study Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3241 - 3251. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, G. Landberg, H. Olsson, and E. Wirfalt Plant foods and oestrogen receptor {alpha}- and {beta}-defined breast cancer: observations from the Malmo Diet and Cancer cohort Carcinogenesis, November 1, 2008; 29(11): 2203 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Honma, R. Horii, T. Iwase, S. Saji, M. Younes, K. Takubo, M. Matsuura, Y. Ito, F. Akiyama, and G. Sakamoto Clinical Importance of Estrogen Receptor-{beta} Evaluation in Breast Cancer Patients Treated With Adjuvant Tamoxifen Therapy J. Clin. Oncol., August 1, 2008; 26(22): 3727 - 3734. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sugiura, T. Toyama, Y. Hara, Z. Zhang, S. Kobayashi, Y. Fujii, H. Iwase, and H. Yamashita Expression of Estrogen Receptor Wild-type and its Variant ER cx/ 2 is Correlated with Better Prognosis in Breast Cancer Jpn. J. Clin. Oncol., November 1, 2007; 37(11): 820 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Silva and M. A. Shupnik Integration of Steroid and Growth Factor Pathways in Breast Cancer: Focus on Signal Transducers and Activators of Transcription and Their Potential Role in Resistance Mol. Endocrinol., July 1, 2007; 21(7): 1499 - 1512. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||